Markets are Closed
BIO
Bio-Rad Laboratories Inc. Class A
Open
—
Previous Open
High
573.49
Previous High
Low
554.07
Previous Low
Close
554.98
Previous Close
Volume
249,139
Previous Volume
Company Profile
Description
Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.
Exchange
New York Stock Exchange
List Date
January 02, 1990
CEO
Norman Schwartz
Employees
8,150
Related Stocks
Financials
Revenue
2.31B
Earnings
2.28B
2B
1B
1B
672M
57M
2015
2016
2017
2018
Splits
| March 08, 2002 | 0.50% |
Dividends
No dividends paid to date
Related News
Bio-Rad, Biodesix Partner to Get EUA for Coronavirus Test
Mar 23, 2020 @ 15:16
Bio-Rad (BIO) inks partnership deal with Biodesix to receive a EUA for a ddPCR test....
finance yahoo
Bio-Rad's ddPCR System Detects Coronavirus More Accurately
Mar 20, 2020 @ 14:43
Bio-Rad's (BIO) ddPCR System shows better sensitivity and precision in the detection of SARS-CoV-2, unlike existing qPCR tests....
finance yahoo
Biodesix Partners with Bio-Rad to Bring Emergency Use Authorization (EUA) COVID-19 ddPCR™ Test to the U.S.
Mar 20, 2020 @ 11:00
Biodesix, Inc., a leading diagnostic company in lung disease, today announced a partnership with Bio-Rad Laboratories, Inc. (NYSE:BIO) (NYSE:BIOb) to bring a COVID-19 Droplet Digital PCR (ddPCR) test to the FDA for an Emergency Use Authorization (EUA) approval to support the escalating need for testing...
finance yahoo
New Studies Find Bio-Rad’s QX200 Droplet Digital PCR System Can Detect COVID-19 With Greater Sensitivity and Precision Than Other Existing Molecular Tests
Mar 19, 2020 @ 21:30
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that in two studies published this month, ahead of peer-review, researchers in China reported that Bio-Rad’s QX200 Droplet Digital PCR (ddPCR) System showed superior...
finance yahoo
Bio-Rad Partners with Testing Labs Worldwide to Support COVID-19 Testing
Mar 18, 2020 @ 23:24
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its Real-Time qPCR products are being used by testing laboratories globally to screen for COVID-19....
finance yahoo
Hedge Funds Have Never Been More Bullish On Bio-Rad Laboratories, Inc. (BIO)
Mar 17, 2020 @ 15:27
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]...
finance yahoo
Why Is Bio-Rad (BIO) Down 8.3% Since Last Earnings Report?
Mar 14, 2020 @ 15:30
Bio-Rad (BIO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
finance yahoo
Bio-Rad Launches SARS CoV-2 Standard for Coronavirus Testing
Mar 13, 2020 @ 13:45
With the launch of Bio-Rad's (BIO) SARS CoV-2 Standard, it aims to help laboratories validate coronavirus testing and accelerate the access to testing....
finance yahoo
Bio-Rad Announces that Through its Exact Diagnostics Product Line, the Company has Launched a SARS CoV-2 Standard for Coronavirus (COVID-19) Testing
Mar 12, 2020 @ 23:30
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that through its Exact Diagnostics product line Bio-Rad has launched a SARS CoV-2 Standard to support laboratory assay validation of coronavirus (COVID-19) testing...
finance yahoo
With EPS Growth And More, Bio-Rad Laboratories (NYSE:BIO) Is Interesting
Mar 09, 2020 @ 12:34
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story......
finance yahoo